Results from examining hemp’s ability to fight cancer shows that it might be useful as plant-based treatment for ovarian cancer. Hemp is part of the same cannabis family as marijuana but doesn’t have any psychoactive properties or cause addiction. Hemp contains therapeutically valuable components such as cannabidiol, cannabinol, and tetrahydrocannabinol.
Studies examined the therapeutic potential of an extract known as KY-hemp, which is produced from hemp grown in Kentucky. The plant strain, growing conditions and processing techniques were all optimized to produce an extract containing substances with potential therapeutic benefit and to eliminate any residue that could contaminate the product.
In a study, the researchers found that adding various doses of KY-hemp extract to cultured ovarian cells led to significant dose-dependent slowing of cell migration. This showed that the extract might be useful for stopping metastasis- the spreading of cancer to other parts of the body. In another study,experiments with cultured ovarian cancer cells showed that KY-hemp slowed the secretion of the interleukin IL-1 beta.
Interleukins produce inflammation that can be damaging and has been linked to cancer progression. The hemp-induced slowing of IL-1 β secretion represents a possible biological mechanism responsible for KY-hemp’s anti-cancer effects. The two studies showed that KY hemp is better than the current ovarian cancer drug- Cisplatin.
haleplushearty.org